QTERN Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

There is no information available on overdose with Saxagliptin/Dapagliflozin (QTERN). In the event of an overdose, appropriate supportive treatment should be initiated as dictated by the patient's clinical status. Saxagliptin and its major metabolite are removed by haemodialysis (23% of dose over four hours). The removal of dapagliflozin by haemodialysis has not been studied.

Manufacturer:

AstraZeneca

Distributor:

AstraZeneca